Novel Lupus Approach Yields Mixed Results in Early Trial
Hints of benefit seen in patients with more active disease
Source: medpagetoday.com
Stay updated with breaking news from James Posada. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hints of benefit seen in patients with more active disease
/PRNewswire/ -- Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced that its phase 2...